|
Amgen drug for allergy asthma shows promise in early tests
SFGate An experimental compound from Amgen Inc. succeeded in blunting allergic asthma attacks by blocking a protein newly found to cause symptoms, researchers said. The drug, called AMG 157, focuses on a signaling protein known as thymic stromal … Novel Biologic Promising for Allergic Asthma New antibody can improve quality of life for individuals with asthma New Amgen drug shows early promise for managing allergic asthma attacks |
View full post on asthma – Google News